Open original FDA record ↗Recall record
- FDA identifier
- Z-1121-2022
- Company in FDA record
- Accriva Diagnostics, Inc.
- FDA record creation date
- May 20, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Two whole blood Platelet Reactivity tests exist that share the same reagent formulation and are used to obtain P2Y12 Reactivity Unit results. The test without US-FDA market clearance was distributed and it displays BASE results not displayed by the US-FDA market cleared device. A formula is being provided to health care personnel to calculate the percentage of platelet aggregation inhibition.
Source facts
- Action
- On 03/30/22, recall notices were distributed to customers who were asked to do the following: 1) Forward the notice within their organization and all other organizations where affected devices may have been transferred to. 2) Identify affected devices and do not use. 3) Destroy all affected devices and document the destruction on the Tracking Form. 4) Complete and return the Tracking Form to the recalling firm. Customers with additional questions can contact Customer Service at 800-955-9525 or e-mail customerservice.na@werfen.com
- Initiated
- 2022-03-30
- Root cause
- Employee error
- Terminated
- 2024-11-07
- Distribution
- US Nationwide distribution in the state of California.
- Recall number
- Z-1121-2022
- Recall status
- Terminated
- CDRH record ID
- 192946
- FDA record created
- 2022-05-20
- Recall event number
- 89936